NCT03258502View on ClinicalTrials.gov

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 19, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

RV521

RV521 drug in capsules

DRUG

Placebo

Placebo in capsules

Trial Locations (1)

Unknown

hVIVO Services Ltd, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03258502 - A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection | Biotech Hunter | Biotech Hunter